Skip to main content

Apidra SoloStar Side Effects

Generic name: insulin glulisine

Medically reviewed by Drugs.com. Last updated on Feb 10, 2024.

Note: This document provides detailed information about Apidra SoloStar.

Applies to insulin glulisine: parenteral injection Side Effects associated with insulin glulisine. Some dosage forms listed on this page may not apply specifically to the brand name Apidra SoloStar.

Applies to insulin glulisine: parenteral injection.

Side effects include:

Hypoglycemia, systemic hypersensitivity, injection site reaction.

For healthcare professionals

Applies to insulin glulisine: injectable solution, subcutaneous solution.

General

The most common adverse reactions reported include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, and rash.[Ref]

Metabolic

Hypersensitivity

In clinical trials of ups to 12 months duration, potential systemic allergic reactions were reported in 4.3% (79 of 1833) patients receiving insulin glulisine compared with 3.8% (58 of 1524) patients receiving comparator short-acting insulins. Permanent discontinuation occurred in 1 patient receiving insulin glulisine.[Ref]

Local

Among patients using continuous subcutaneous insulin infusion pumps, the rates of catheter occlusions and infusion site reactions were similar with insulin glulisine compared with insulin aspart.[Ref]

Cardiovascular

Gastrointestinal

Dermatologic

Immunologic

Respiratory

Musculoskeletal

Nervous system

Genitourinary

References

1. (2004) "Product Information. Apidra (insulin glulisine)." Aventis Pharmaceuticals

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

Frequently asked questions

Further information

Apidra SoloStar side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.